PARP2 and lung carcinoma: PARP activation occurs in the muscles of mice that develop lung cancer,41 and deletion of either PARP1 or PARP2 reduces body weight loss, decreases the expression of genes involved in muscle proteolysis, and promotes the expression of anabolic markers in lung cancer‐induced cachexia.41